Neurocrine Biosciences, Inc. (NBIX)
141.20
+3.27
(+2.37%)
USD |
NASDAQ |
Feb 06, 16:00
141.22
+0.02
(+0.01%)
After-Hours: 20:00
Neurocrine Biosciences SG&A Expense (TTM) : 1.142B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.79B |
| Bio-Rad Laboratories, Inc. | 827.30M |
| Edwards Lifesciences Corp. | 1.974B |
| Masimo Corp. | 596.30M |
| Marker Therapeutics, Inc. | 4.365M |